CFH and atypical hemolytic-uremic syndrome: Analysis of the antibody binding sites demonstrated recognition of several parts of factor H, including both the N- and C-terminal domains of the molecule, a pattern different from that seen in atypical hemolytic uremic syndrome (see below) [106].